Search

Your search keyword '"Humira (Medication) -- Prices and rates"' showing total 1 results
Start Over Descriptor "Humira (Medication) -- Prices and rates" Journal crain's chicago business

Refine your results

1 results on '"Humira (Medication) -- Prices and rates"'

1. AbbVie will feel the squeeze under new drug pricing law; Its blockbuster Humira is on a new list of 27 drugs that saw prices rise faster than inflation in 2022 -- triggering penalties and rebates under rules passed last year

Subjects
United States. Department of Health and Human Services -- Laws, regulations and rules, Social service -- Prices and rates, Pricing -- Laws, regulations and rules, Antiarthritic agents -- Prices and rates, Inflation (Finance) -- Laws, regulations and rules, Pharmaceutical industry -- Prices and rates -- Laws, regulations and rules, Government regulation, Product price, Company pricing policy, Business, Business, regional, Humira (Medication) -- Prices and rates
Abstract

Byline: Katherine Davis Humira, the rheumatoid arthritis medication made by pharmaceutical giant AbbVie, is among the first group of drugs that will face a penalty under a new law prohibiting [...]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results